The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine
Open accessAbstract
Objective Early-onset epileptic encephalopathies have been associated with de novo mutations of numerous ion channel genes. We employed techniques of modern translational medicine to identify a disease-causing mutation, analyze its altered behavior, and screen for therapeutic compounds to treat the proband. Methods Three modern translational medicine tools were utilized: (1) high-throughput sequencing technology to identify a novel de novo mutation; (2) in vitro expression and electrophysiology assays to confirm the variant protein's dysfunction; and (3) screening of existing drug libraries to identify potential therapeutic compounds. Results A de novo GRIN2A missense mutation (c.2434C>A; p.L812M) increased the charge transfer mediated by N-methyl-D-aspartate receptors (NMDAs) containing the mutant GluN2A-L812M subunit. In vitro analysis with NMDA receptor blockers indicated that GLuN2A-L812M-containing NMDARs retained their sensitivity to the use-dependent channel blocker memantine; while screening of a previously reported GRIN2A mutation (N615K) with these compounds produced contrasting results. Consistent with these data, adjunct memantine therapy reduced our proband's seizure burden. Interpretation This case exemplifies the potential for personalized genomics and therapeutics to be utilized for the early diagnosis and treatment of infantile-onset neurological disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Self-citationMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor
Sobolevsky, A. I., Rosconi, M. P., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08624 · Cited by 1,026
Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., Milh, M., Kortüm, F., Fritsch, A., Pientka, F. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.677 · Cited by 499
Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S., & Mizuno, N. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903470112 · Cited by 486
Lesca, G., Rudolf, G., Bruneau, N., Lozovaya, N., Labalme, A., Boutry-Kryza, N., Salmi, M., Tsintsadze, T., Addis, L., Motte, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2726 · Cited by 439
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes
Lemke, J. R., Lal, D., Reinthaler, E. M., Steiner, I., Nothnagel, M., Alber, M., Geider, K., Laube, B., Schwake, M., Finsterwalder, K., et al. (2013) · Nature Genetics · doi:10.1038/ng.2728 · Cited by 430
Chapter 6 Glutamate receptors and the induction of excitotoxic neuronal death
Choi, D. W. (1994) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60767-0 · Cited by 385
GRIN2A mutations cause epilepsy-aphasia spectrum disorders
Carvill, G. L., Regan, B. M., Yendle, S. C., O'Roak, B. J., Lozovaya, N., Bruneau, N., Burnashev, N., Khan, A., Cook, J., Geraghty, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2727 · Cited by 376
Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349
The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases
Gahl, W. A., Markello, T. C., Toro, C., Fajardo, K. F., Sincan, M., Gill, F., Carlson-Donohoe, H., Gropman, A., Pierson, T. M., Golas, G., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e318232a005 · Cited by 291
Self-citationControl of Voltage-Independent Zinc Inhibition of NMDA Receptors by the NR1 Subunit
Traynelis, S. F., Burgess, M. F., Zheng, F., Lyuboslavsky, P., & Powers, J. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06163.1998 · Cited by 268
Self-citationA Unified Model of the Presynaptic and Postsynaptic Changes During LTP at CA1 Synapses
Lisman, J., & Raghavachari, S. (2006) · Science's STKE · doi:10.1126/stke.3562006re11 · Cited by 241
Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F. F., Xiong, L., Piton, A., Spiegelman, D., Henrion, É., Millet, B., S2D team, et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.52 · Cited by 231
Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302611 · Cited by 221
The NMDA receptor complex as a therapeutic target in epilepsy: a review
Ghasemi, M., & Schachter, S. C. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.07.024 · Cited by 187
Erickson, C. A., Posey, D. J., Stigler, K. A., Mullett, J., Katschke, A. R., & McDougle, C. J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0518-9 · Cited by 159
Wollmuth, L. P., Kuner, T., & Sakmann, B. J. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.013bx.x · Cited by 156
Yuan, H., Hansen, K. B., Zhang, J., Pierson, T. M., Markello, T. C., Fajardo, K. V. F., Holloman, C., Golas, G. A., Adams, D. R., Boerkoel, C. F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4251 · Cited by 143
Self-citationThe NIH Undiagnosed Diseases Program
Gahl, W. A. (2011) · JAMA · doi:10.1001/jama.2011.613 · Cited by 124
Self-citationAcker, T. M., Yuan, H., Hansen, K. B., Vance, K. M., Ogden, K. K., Jensen, H. S., Burger, P. B., Mullasseril, P., Snyder, J. P., Liotta, D. C., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073239 · Cited by 108
Self-citationReutlinger, C., Helbig, I., Gawelczyk, B., Martín-Subero, J. I., Tönnies, H., Muhle, H., Finsterwalder, K., Vermeer, S., Pfundt, R., Sperner, J., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02555.x · Cited by 102
Molecular pharmacology of human NMDA receptors
Hedegaard, M. K., Hansen, K. B., Andersen, K. T., Bräuner‐Osborne, H., & Traynelis, S. F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.016 · Cited by 81
Self-citationTalukder, I., Borker, P., & Wollmuth, L. P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5382-09.2010 · Cited by 75
Mullikin, J. C., Pierson, T. M., Simeonov, D. R., Sincan, M., Adams, D. R., Markello, T. C., Golas, G. A., Fajardo, K. V. F., Hansen, N. F., Cherukuri, P. F., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.222 · Cited by 59
Self-citationLePage, K. T., Ishmael, J. E., Low, C. M., Traynelis, S. F., & Murray, T. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.029 · Cited by 45
Self-citationPujar, S. S., Calvert, S., Cortina‐Borja, M., Chin, R., Smith, R. A., Cross, J. H., Das, K. B., Pitt, M. C., & Scott, R. C. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.07.013 · Cited by 21
Cited by
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Self-citationThe genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Drug development in the era of precision medicine
Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Marwaha, S., Knowles, J. W., & Ashley, E. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01026-w · Cited by 359
Metadata
- Authors
- Pierson, T. M., Yuan, H., Marsh, E. D., Fuentes‐Fajardo, K., Adams, D. R., Markello, T., Golas, G., Simeonov, D. R., Holloman, C., Tankovic, A., Karamchandani, M. M., Schreiber, J. M., Mullikin, J. C., Tifft, C. J., Toro, C., Boerkoel, C. F., Traynelis, S. F., & Gahl, W. A.
- Venue
- Annals of Clinical and Translational Neurology
- Publisher
- Wiley
- Published
- 2014-03
- Volume
- 1
- Issue
- 3
- Pages
- 190-198
- ISSN
- 2328-9503 (ISSN-L)
- OpenAlex
- W1987093811
- Cited by
- 298
- References
- 28
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.